However, the association of the combined CD3+ TIL density and CD24 expression status with MFS is probably the most critical in patients with LA-NPC, as local relapse can be retreated with CCRT, while managing LA-NPC is much more challenging once it becomes metastatic. The gene discussed is CD24; the disease is nasopharyngeal carcinoma.